ASGE guideline

The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract

William K. Hirota, Marc J. Zuckerman, Douglas G. Adler, Raquel E. Davila, James Egan, Jonathan A Leighton, Waqar A. Qureshi, Elizabeth Rajan, Robert Fanelli, Jo Wheeler-Harbaugh, Todd H. Baron, Douglas Orrick Faigel

Research output: Contribution to journalArticle

370 Citations (Scopus)

Abstract

Patients with chronic GERD at risk for Barrett's esophagus should be considered for endoscopic screening (B). In patients with Barrett's esophagus without dysplasia, the cost effectiveness of surveillance endoscopy is controversial. If surveillance is performed, an interval of 3 years is acceptable (). Although an increased cancer risk has not been established in patients with Barrett's esophagus and low grade dysplasia, endoscopy at 6 months and yearly thereafter should be considered (C). Patients with Barrett's esophagus with confirmed HGD should be considered for surgery or aggressive endoscopic therapy (B). Patients with HGD who elect endoscopic surveillance should be followed-up closely (ie, every 3 months) for at least 1 year. If no further HGD is confirmed, then the interval between follow-ups may be lengthened (B). There are insufficient data to recommend routine surveillance for patients with achalasia (C). Patients with a severe caustic esophageal injury should undergo surveillance every 1 to 3 years beginning 15 to 20 years after the injury (C). Patients with tylosis should undergo surveillance endoscopy every 1 to 3 years beginning at age 30 years (C). There are insufficient data to support routine endoscopic surveillance for patients with previous aerodigestive squamous cell cancer (C). Adenomatous gastric polyps should be resected because of the risk for malignant transformation (B). Adenomatous polyps may recur in synchronous and metachronous sites, and surveillance endoscopies should be performed at 3- to 5-year intervals (C). Endoscopic surveillance for gastric intestinal metaplasia has not been extensively studied in the U.S. and therefore cannot be routinely recommended (C). However, there may be a subgroup of high-risk patients who will benefit from endoscopic surveillance (B). Patients with confirmed gastric high-grade dysplasia should be considered for gastrectomy or local resection because of the high incidence of prevalent carcinoma (B). Patients with pernicious anemia may be considered for a single screening endoscopy, particularly if symptomatic, but there are insufficient data to recommend ongoing surveillance (C). There are insufficient data to support routine endoscopic surveillance in patients with previous partial gastrectomy for peptic ulcer disease (C). Patients with FAP should undergo regular surveillance endoscopy using both end-viewing and side-viewing endoscopes, starting around the time of colectomy or after age 30 years (B). Patients with HNPCC have an increased risk of gastric and small-bowel cancer (B). Surveillance should be strongly considered (C).

Original languageEnglish (US)
Pages (from-to)570-580
Number of pages11
JournalGastrointestinal Endoscopy
Volume63
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

Upper Gastrointestinal Tract
Endoscopy
Guidelines
Barrett Esophagus
Stomach
Adenomatous Polyps
Gastrectomy
Keratoderma, Palmoplantar, Diffuse
Intestinal Neoplasms
Pernicious Anemia
Squamous Cell Neoplasms
Caustics
Esophageal Achalasia
Colectomy
Endoscopes
Wounds and Injuries
Metaplasia
Gastroesophageal Reflux
Peptic Ulcer

ASJC Scopus subject areas

  • Gastroenterology

Cite this

ASGE guideline : The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. / Hirota, William K.; Zuckerman, Marc J.; Adler, Douglas G.; Davila, Raquel E.; Egan, James; Leighton, Jonathan A; Qureshi, Waqar A.; Rajan, Elizabeth; Fanelli, Robert; Wheeler-Harbaugh, Jo; Baron, Todd H.; Faigel, Douglas Orrick.

In: Gastrointestinal Endoscopy, Vol. 63, No. 4, 04.2006, p. 570-580.

Research output: Contribution to journalArticle

Hirota, WK, Zuckerman, MJ, Adler, DG, Davila, RE, Egan, J, Leighton, JA, Qureshi, WA, Rajan, E, Fanelli, R, Wheeler-Harbaugh, J, Baron, TH & Faigel, DO 2006, 'ASGE guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract', Gastrointestinal Endoscopy, vol. 63, no. 4, pp. 570-580. https://doi.org/10.1016/j.gie.2006.02.004
Hirota, William K. ; Zuckerman, Marc J. ; Adler, Douglas G. ; Davila, Raquel E. ; Egan, James ; Leighton, Jonathan A ; Qureshi, Waqar A. ; Rajan, Elizabeth ; Fanelli, Robert ; Wheeler-Harbaugh, Jo ; Baron, Todd H. ; Faigel, Douglas Orrick. / ASGE guideline : The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. In: Gastrointestinal Endoscopy. 2006 ; Vol. 63, No. 4. pp. 570-580.
@article{604ebcb64f1b4ec389e4824885c5ad34,
title = "ASGE guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract",
abstract = "Patients with chronic GERD at risk for Barrett's esophagus should be considered for endoscopic screening (B). In patients with Barrett's esophagus without dysplasia, the cost effectiveness of surveillance endoscopy is controversial. If surveillance is performed, an interval of 3 years is acceptable (). Although an increased cancer risk has not been established in patients with Barrett's esophagus and low grade dysplasia, endoscopy at 6 months and yearly thereafter should be considered (C). Patients with Barrett's esophagus with confirmed HGD should be considered for surgery or aggressive endoscopic therapy (B). Patients with HGD who elect endoscopic surveillance should be followed-up closely (ie, every 3 months) for at least 1 year. If no further HGD is confirmed, then the interval between follow-ups may be lengthened (B). There are insufficient data to recommend routine surveillance for patients with achalasia (C). Patients with a severe caustic esophageal injury should undergo surveillance every 1 to 3 years beginning 15 to 20 years after the injury (C). Patients with tylosis should undergo surveillance endoscopy every 1 to 3 years beginning at age 30 years (C). There are insufficient data to support routine endoscopic surveillance for patients with previous aerodigestive squamous cell cancer (C). Adenomatous gastric polyps should be resected because of the risk for malignant transformation (B). Adenomatous polyps may recur in synchronous and metachronous sites, and surveillance endoscopies should be performed at 3- to 5-year intervals (C). Endoscopic surveillance for gastric intestinal metaplasia has not been extensively studied in the U.S. and therefore cannot be routinely recommended (C). However, there may be a subgroup of high-risk patients who will benefit from endoscopic surveillance (B). Patients with confirmed gastric high-grade dysplasia should be considered for gastrectomy or local resection because of the high incidence of prevalent carcinoma (B). Patients with pernicious anemia may be considered for a single screening endoscopy, particularly if symptomatic, but there are insufficient data to recommend ongoing surveillance (C). There are insufficient data to support routine endoscopic surveillance in patients with previous partial gastrectomy for peptic ulcer disease (C). Patients with FAP should undergo regular surveillance endoscopy using both end-viewing and side-viewing endoscopes, starting around the time of colectomy or after age 30 years (B). Patients with HNPCC have an increased risk of gastric and small-bowel cancer (B). Surveillance should be strongly considered (C).",
author = "Hirota, {William K.} and Zuckerman, {Marc J.} and Adler, {Douglas G.} and Davila, {Raquel E.} and James Egan and Leighton, {Jonathan A} and Qureshi, {Waqar A.} and Elizabeth Rajan and Robert Fanelli and Jo Wheeler-Harbaugh and Baron, {Todd H.} and Faigel, {Douglas Orrick}",
year = "2006",
month = "4",
doi = "10.1016/j.gie.2006.02.004",
language = "English (US)",
volume = "63",
pages = "570--580",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - ASGE guideline

T2 - The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract

AU - Hirota, William K.

AU - Zuckerman, Marc J.

AU - Adler, Douglas G.

AU - Davila, Raquel E.

AU - Egan, James

AU - Leighton, Jonathan A

AU - Qureshi, Waqar A.

AU - Rajan, Elizabeth

AU - Fanelli, Robert

AU - Wheeler-Harbaugh, Jo

AU - Baron, Todd H.

AU - Faigel, Douglas Orrick

PY - 2006/4

Y1 - 2006/4

N2 - Patients with chronic GERD at risk for Barrett's esophagus should be considered for endoscopic screening (B). In patients with Barrett's esophagus without dysplasia, the cost effectiveness of surveillance endoscopy is controversial. If surveillance is performed, an interval of 3 years is acceptable (). Although an increased cancer risk has not been established in patients with Barrett's esophagus and low grade dysplasia, endoscopy at 6 months and yearly thereafter should be considered (C). Patients with Barrett's esophagus with confirmed HGD should be considered for surgery or aggressive endoscopic therapy (B). Patients with HGD who elect endoscopic surveillance should be followed-up closely (ie, every 3 months) for at least 1 year. If no further HGD is confirmed, then the interval between follow-ups may be lengthened (B). There are insufficient data to recommend routine surveillance for patients with achalasia (C). Patients with a severe caustic esophageal injury should undergo surveillance every 1 to 3 years beginning 15 to 20 years after the injury (C). Patients with tylosis should undergo surveillance endoscopy every 1 to 3 years beginning at age 30 years (C). There are insufficient data to support routine endoscopic surveillance for patients with previous aerodigestive squamous cell cancer (C). Adenomatous gastric polyps should be resected because of the risk for malignant transformation (B). Adenomatous polyps may recur in synchronous and metachronous sites, and surveillance endoscopies should be performed at 3- to 5-year intervals (C). Endoscopic surveillance for gastric intestinal metaplasia has not been extensively studied in the U.S. and therefore cannot be routinely recommended (C). However, there may be a subgroup of high-risk patients who will benefit from endoscopic surveillance (B). Patients with confirmed gastric high-grade dysplasia should be considered for gastrectomy or local resection because of the high incidence of prevalent carcinoma (B). Patients with pernicious anemia may be considered for a single screening endoscopy, particularly if symptomatic, but there are insufficient data to recommend ongoing surveillance (C). There are insufficient data to support routine endoscopic surveillance in patients with previous partial gastrectomy for peptic ulcer disease (C). Patients with FAP should undergo regular surveillance endoscopy using both end-viewing and side-viewing endoscopes, starting around the time of colectomy or after age 30 years (B). Patients with HNPCC have an increased risk of gastric and small-bowel cancer (B). Surveillance should be strongly considered (C).

AB - Patients with chronic GERD at risk for Barrett's esophagus should be considered for endoscopic screening (B). In patients with Barrett's esophagus without dysplasia, the cost effectiveness of surveillance endoscopy is controversial. If surveillance is performed, an interval of 3 years is acceptable (). Although an increased cancer risk has not been established in patients with Barrett's esophagus and low grade dysplasia, endoscopy at 6 months and yearly thereafter should be considered (C). Patients with Barrett's esophagus with confirmed HGD should be considered for surgery or aggressive endoscopic therapy (B). Patients with HGD who elect endoscopic surveillance should be followed-up closely (ie, every 3 months) for at least 1 year. If no further HGD is confirmed, then the interval between follow-ups may be lengthened (B). There are insufficient data to recommend routine surveillance for patients with achalasia (C). Patients with a severe caustic esophageal injury should undergo surveillance every 1 to 3 years beginning 15 to 20 years after the injury (C). Patients with tylosis should undergo surveillance endoscopy every 1 to 3 years beginning at age 30 years (C). There are insufficient data to support routine endoscopic surveillance for patients with previous aerodigestive squamous cell cancer (C). Adenomatous gastric polyps should be resected because of the risk for malignant transformation (B). Adenomatous polyps may recur in synchronous and metachronous sites, and surveillance endoscopies should be performed at 3- to 5-year intervals (C). Endoscopic surveillance for gastric intestinal metaplasia has not been extensively studied in the U.S. and therefore cannot be routinely recommended (C). However, there may be a subgroup of high-risk patients who will benefit from endoscopic surveillance (B). Patients with confirmed gastric high-grade dysplasia should be considered for gastrectomy or local resection because of the high incidence of prevalent carcinoma (B). Patients with pernicious anemia may be considered for a single screening endoscopy, particularly if symptomatic, but there are insufficient data to recommend ongoing surveillance (C). There are insufficient data to support routine endoscopic surveillance in patients with previous partial gastrectomy for peptic ulcer disease (C). Patients with FAP should undergo regular surveillance endoscopy using both end-viewing and side-viewing endoscopes, starting around the time of colectomy or after age 30 years (B). Patients with HNPCC have an increased risk of gastric and small-bowel cancer (B). Surveillance should be strongly considered (C).

UR - http://www.scopus.com/inward/record.url?scp=33645240406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645240406&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2006.02.004

DO - 10.1016/j.gie.2006.02.004

M3 - Article

VL - 63

SP - 570

EP - 580

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 4

ER -